Evidence map›Paper›PMID 36460176›Full record

ArticleThe Journal of hospital infection2023

Risk of transmission of COVID-19 from healthcare workers returning to work after a 5-day isolation, and kinetics of shedding of viable SARS-CoV-2 variant B.1.1.529 (Omicron).

J Jung, S W Kang, S Lee, H Park, J Y Kim, S-K Kim, S Park, Y-J Lim, E O Kim, S Y Lim and 9 more

Open access · greenAbstract read
In one paragraph

Article in The Journal of hospital infection, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 2 pooled it
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 2 syntheses or guidelines pooled it, 10 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 4 institutions in 1 country.

J JungDepartment of Infectious Diseases, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea; Office for Infection Control, Asan Medical Center, Seoul, South Korea.
S W KangDepartment of Infectious Diseases, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
S LeeOffice for Infection Control, Asan Medical Center, Seoul, South Korea.
H ParkDepartment of Microbiology, Institute for Viral Diseases, Vaccine Innovation Center, College of Medicine, Korea University, Seoul, South Korea.
J Y KimDepartment of Infectious Diseases, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
S-K KimOffice for Infection Control, Asan Medical Center, Seoul, South Korea.
S ParkOffice for Infection Control, Asan Medical Center, Seoul, South Korea.
Y-J LimOffice for Infection Control, Asan Medical Center, Seoul, South Korea.
E O KimOffice for Infection Control, Asan Medical Center, Seoul, South Korea.
S Y LimDepartment of Infectious Diseases, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
E ChangDepartment of Infectious Diseases, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
S BaeDepartment of Infectious Diseases, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
M J KimDepartment of Infectious Diseases, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
Y P ChongDepartment of Infectious Diseases, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
S-O LeeDepartment of Infectious Diseases, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
S-H ChoiDepartment of Infectious Diseases, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
Y S KimDepartment of Infectious Diseases, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
M-S ParkDepartment of Microbiology, Institute for Viral Diseases, Vaccine Innovation Center, College of Medicine, Korea University, Seoul, South Korea. Electronic address: manseong.park@gmail.com.
S-H KimDepartment of Infectious Diseases, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea; Office for Infection Control, Asan Medical Center, Seoul, South Korea. Electronic address: kimsunghanmd@hotmail.com.
Asan Medical Center · KRUlsan College · KRUniversity of Ulsan · KRKorea University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThere have been limited data on the risk of onward transmission from individuals with Omicron variant infections who return to work after a 5-day isolation.

aimTo evaluate the risk of transmission from healthcare workers (HCWs) with Omicron variant who returned to work after a 5-day isolation and the viable-virus shedding kinetics.

methodsThis investigation was performed in a tertiary care hospital, Seoul, South Korea. In a secondary transmission study, we retrospectively reviewed the data of HCWs confirmed as COVID-19 from March 14

findingsOf the 248 HCWs who were diagnosed with COVID-19 within 5 days of the return of an infected HCW, 18 (7%) had contact with the returned HCW within 1-5 days after their return. Of these, nine (4%) had an epidemiologic link other than with the returning HCW, and nine (4%) had contact with the returning HCW, without any other epidemiologic link. In the study of the kinetics of virus shedding (N = 32), the median time from symptom onset to negative conversion of viable virus was four days (95% confidence interval: 3-5).

conclusionOur data suggest that the residual risk of virus transmission after 5 days of isolation following diagnosis or symptom onset is low.

Indexed as

COVID-19Health PersonnelHumansKineticsRetrospective StudiesSARS-CoV-2COVID-19IsolationSARS-CoV-2Transmission

Identifiers

PMID36460176
PMCPMC9705265
OpenAlexW4310191862

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.